Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Post-Operative Pericardial Effusion (POPE 2)
NCT01266694Phase 4Completed
- Sponsor
- Société Française de Cardiologie
- Start
- Apr 2011
- Primary completion
- Mar 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of colchicine in pericardial effusion, sponsored by Société Française de Cardiologie. Primary endpoint: Change in effusion grade at 14 days. Started Apr 2011; status: completed.
02
Drugs
colchicine
03
Conditions
pericardial effusion
Beyond the preview
Go deeper on NCT01266694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266694.